MTT GmbH

MTT GmbH specializes in brachytherapy-related devices, focusing on software applications and applicators for high-dose-rate (HDR) radiotherapy. Their portfolio includes software tools like BioJet Target and EndoMotion, which assist in planning and targeting, as well as reusable and disposable PeriGrid applicators in multiple gauges (ranging from 13G to 18G). They also produce precision locking mechanisms like SolidLock Ff and targeting systems such as TargetPro. These devices are designed to enhance accuracy and efficiency in brachytherapy procedures.

MTT GmbH is based in Germany. The company’s primary focus is developing brachytherapy system application software and specialized applicators for HDR radiotherapy. Their solutions aim to improve precision in treatment planning, delivery, and targeting, catering to clinical needs in radiation oncology.

MTT GmbH’s devices are listed in EUDAMED, the European Union’s medical device registry, and the FDA’s UDI system, ensuring traceability and compliance tracking for their products under relevant regulatory frameworks. These listings help healthcare providers and authorities verify device details and classifications.

MTT GmbH’s devices fall under Class I, Class II, and Class IIa classifications under the EU Medical Device Regulation (MDR). The classification depends on factors like risk level, intended use, and design features—such as reusable applicators (Class IIa) or lower-risk software tools (Class I). This categorization determines regulatory requirements for compliance, labeling, and post-market surveillance.